Manila Bulletin
Gov’t on track to acquire 170 M vaccine doses; enough to inoculate 70 M Filipinos
The Philippine government is on track to secure 170 million doses of COVID-19 vaccines to inoculate between 50 to 70 million Filipinos this year.
Presidential Spokesperson Harry Roque affirmed that the target of acquiring 170 million vaccine doses will be met, citing vaccine czar Carlito Galvez Jr.
The country's vaccine supply includes 44 million doses from the WHO's COVAX Facility, with confirmed deliveries of AstraZeneca and Pfizer vaccines in the first half of the year.
Despite initial delays, the first batch of 117,000 Pfizer vaccine doses is expected to arrive this month.
Additional vaccine supplies are anticipated from Sinovac (25 million doses starting this month), Gamaleya National Center (10 to 15 million doses starting April), and Novavax (30 million doses starting May).
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines is aiming to complete its COVID-19 vaccination program by 2023, with a possibility of achieving good outcomes by 2022.
Read more →
The Philippine government aims to secure enough vaccines for 70 million Filipinos by the end of 2021, despite delays in the first Pfizer-BioNTech shipment from COVAX.
Read more →
The Philippines is expecting 600,000 doses of the Sinovac COVID-19 vaccine to arrive on February 23.
Read more →
Vaccine czar Secretary Carlito Galvez, Jr. warned of a potential COVID-19 vaccine shortage in the Philippines during the first and second quarters of 2021 due to high demand from Europe and the United States.
Read more →
The Philippines will not lose its 44 million vaccine allocation from the COVAX facility despite a one-week delay in the delivery of Pfizer vaccines.
Read more →